Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $717.47 million. The enterprise value is $363.36 million.

Market Cap	717.47M
Enterprise Value	363.36M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

ORKA has 35.00 million shares outstanding.

Current Share Class	35.00M
Shares Outstanding	35.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	53.53%
Float	23.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	2.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.89, with a Debt / Equity ratio of 0.00.

Current Ratio	22.89
Quick Ratio	22.78
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.65%
50-Day Moving Average	26.25
200-Day Moving Average	32.30
Relative Strength Index (RSI)	29.96
Average Volume (20 Days)	174,520

Short Selling Information

The latest short interest is 783,783, so 2.24% of the outstanding shares have been sold short.

Short Interest	783,783
Short Previous Month	607,451
Short % of Shares Out	2.24%
Short % of Float	3.35%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $410.88 million in cash and $988,000 in debt, giving a net cash position of $409.89 million or $11.71 per share.

Cash & Cash Equivalents	410.88M
Total Debt	988,000
Net Cash	409.89M
Net Cash Per Share	$11.71
Equity (Book Value)	342.37M
Book Value Per Share	n/a
Working Capital	394.91M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for ORKA is $43.60, which is 112.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$43.60
Price Target Difference	112.68%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 0.083333333:1.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	0.083333333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a